Wilms tumor is an embryonal kidney cancer of children that exhibits aberrant nephrogenesis and thus provides a model system to study the molecular events underlying the developing kidney. This tumor is associated with anomalies in the urogenitary system and present evidence suggests a shared genetic origin for Wilms tumor and associated urogenitary abnormalities. We have cloned and characterized two linked, divergently transcribed genes, WT1 and WIT-1, implicated in Wilms tumorigenesis by virtue of being deleted or mutated in tumor DNA. Germline mutations in a single WT1 allele can result in nephropathy, ambiguous genitalia and cryptorchidism (the Denys Drash syndrome). Loss of expression from both alleles results in Wilms tumor. In the normal developing kidney, WT1 and WIT-1 are expressed only in the condensing metanephric mesenchyme or developing glomeruli. Thus these genes must respond to induction following interaction of the metanephric mesenchyme and the epithelial ureteric bud and likely regulate the expression of other genes involved in differentiation and morphogenesis. Our long term objective is to determine how the WT1 and WIT-1 genes function in nephrogenesis and pathogenesis of the kidney and urogenitary system. In order to determine how the temporal and spatial expression of the WT1 and WIT-1 genes is controlled,to define downstream targets for regulation by these genes, and describe the functional consequences of aberrant the expression of these genes, we propose to establish and study animal and cell culture models of nephrogenesis.
The specific aims are: 1) To define the cells of origin of expression of the WT1 and WIT-1 genes and their candidate target genes using in situ hybridization and immunocytochemistry thereby establishing expression patterns in the developing mouse embryo. 2) To delineate the promoter elements of the WT1 and WIT-1 genes necessary for the correct temporal and spatial expression we will map DNAse 1 hypersensitive sites and use this information to test different reporter constructs in transgenic mice. 3) To establish transgenic mouse lines in which the expression patterns of the WT1 and WIT-1 genes are perturbed by changing tissue specificity of expression or by maintaining spatial and temporal specificity but disturbing the relative levels of different forms of transcripts that are produced by alternative splicing. This integrated approach will allow us to elucidate fundamental molecular mechanisms of kidney development and provide insight into their dysregulation in kidney and urogenitary disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK047101-04
Application #
2430212
Study Section
Pathology B Study Section (PTHB)
Project Start
1994-06-01
Project End
1999-05-31
Budget Start
1997-06-01
Budget End
1999-05-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Alami, Jennifer; Williams, Bryan R G; Yeger, Herman (2002) Expression and localization of HGF and met in Wilms' tumours. J Pathol 196:76-84
Chen, Y; Williams, B R (2000) The role of NF-kappaB in the regulation of the expression of wilms tumor suppressor gene WT1. Gene Expr 9:103-14
Campbell, C E; Kuriyan, N P; Rackley, R R et al. (1998) Constitutive expression of the Wilms tumor suppressor gene (WT1) in renal cell carcinoma. Int J Cancer 78:182-8
Ye, Y; Vasavada, S; Kuzmin, I et al. (1998) Subcellular localization of the von Hippel-Lindau disease gene product is cell cycle-dependent. Int J Cancer 78:62-9
Hewitt, J A; Kessler, P M; Campbell, C E et al. (1996) Tissue-specific regulation of the WT1 locus. Med Pediatr Oncol 27:456-61
Yeger, H; Forget, D; Alami, J et al. (1996) Analysis of WT1 gene expression during mouse nephrogenesis in organ culture. In Vitro Cell Dev Biol Anim 32:496-504
Ye, Y; Raychaudhuri, B; Gurney, A et al. (1996) Regulation of WT1 by phosphorylation: inhibition of DNA binding, alteration of transcriptional activity and cellular translocation. EMBO J 15:5606-15
Rackley, R R; Kessler, P M; Campbell, C et al. (1995) In situ expression of the early growth response gene-1 during murine nephrogenesis. J Urol 154:700-5